Advertisement
"Sagent is proud to be providing tools to the healthcare community thathave the potential to help reduce medical errors," said Jeffrey M. Yordon,chief executive officer, founder, and chairman of the board of Sagent. "Weare excited to make important products like ceftazidime available withexciting innovations, such as easy-to-read dosage strengths and preciselettering on vial labels that are intended to promote patient safety."
Advertisement
Sagent's introduction of ceftazidime to the U.S. market is the seventhproduct launched from Sagent's pipeline of more than 200 products this year.
About Ceftazidime
Ceftazidime for Injection, USP is a semisynthetic broad-spectrum,beta-lactam antibiotic used to treat bacterial infections, includinginfections of the lower respiratory tract; skin and skin-structure; urinarytract; bone and joint; and central nervous system. Ceftazidime is alsoindicated for bacterial septicemia, gynecologic infections, andintra-abdominal infections. Sagent's ceftazidime is the generic equivalent ofGlaxoSmithKline's FORTAZ(R).
The most common adverse effects include diarrhea, headache, stomach pain,nausea, vomiting, and numbness or tingling of the skin. Less common adverseeffects include abnormal muscle movements, severe stomach cramps, severenausea or vomiting, bloody stools, severe diarrhea, decreased urination,vaginal irritation or discharge, fever, white patches in the mouth,hoarseness, jaundice, injection site reactions, vein inflammation and red,swollen or blistered skin, seizures.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, founded in 2006, is a privately held specialtypharmaceutical company focused on developing, manufacturing, sourcing andmarketing pharmaceutical products, with a specific emphasis on injectableproducts. Sagent has created a unique, global network of resources, comprisedof rapid development capabilities, sophisticated manufacturing and innovativedrug-delivery technologies, quickly yielding an extensive portfolio ofpharmaceutical products that fulfills the evolving needs of patients. Sagentcurrently has more than 200 products in development.
To Discover Injectables Excellence(TM) and learn more about Sagent, pleasevisit http://www.SagentPharma.com.
SOURCE Sagent Pharmaceuticals, Inc.
